- Home
- VATE vs COEP Comparison
VATE vs COEP Comparison
Compare VATE & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- COEP
- Stock Information
- Founded
- VATE 1994
- COEP 2017
- Country
- VATE United States
- COEP United States
- Employees
- VATE N/A
- COEP N/A
- Industry
- VATE Metal Fabrications
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VATE Industrials
- COEP Health Care
- Exchange
- VATE Nasdaq
- COEP Nasdaq
- Market Cap
- VATE 70.3M
- COEP 72.1M
- IPO Year
- VATE 1996
- COEP N/A
- Fundamental
- Price
- VATE $5.06
- COEP $16.91
- Analyst Decision
- VATE
- COEP
- Analyst Count
- VATE 0
- COEP 0
- Target Price
- VATE N/A
- COEP N/A
- AVG Volume (30 Days)
- VATE 41.3K
- COEP 40.5K
- Earning Date
- VATE 11-12-2025
- COEP 11-14-2025
- Dividend Yield
- VATE N/A
- COEP N/A
- EPS Growth
- VATE N/A
- COEP N/A
- EPS
- VATE N/A
- COEP N/A
- Revenue
- VATE $1,099,900,000.00
- COEP $500,996.00
- Revenue This Year
- VATE N/A
- COEP N/A
- Revenue Next Year
- VATE N/A
- COEP N/A
- P/E Ratio
- VATE N/A
- COEP N/A
- Revenue Growth
- VATE N/A
- COEP N/A
- 52 Week Low
- VATE $3.81
- COEP $2.31
- 52 Week High
- VATE $13.79
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- VATE 47.38
- COEP 64.87
- Support Level
- VATE $4.70
- COEP $13.65
- Resistance Level
- VATE $5.89
- COEP $15.07
- Average True Range (ATR)
- VATE 0.39
- COEP 1.11
- MACD
- VATE -0.08
- COEP 0.15
- Stochastic Oscillator
- VATE 33.88
- COEP 95.52
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.